CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids
Abstract Background Predictions based on patient-derived materials of CFTR modulators efficacy have been performed lately in patient-derived cells, extending FDA-approved drugs for CF patients harboring rare variants. Here we developed intestinal organoids from subjects carrying S737F- and T465N-CFT...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2024-09-01
|
| Ráidu: | Orphanet Journal of Rare Diseases |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s13023-024-03334-3 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|